Cargando…

Multi-View Radiomics Feature Fusion Reveals Distinct Immuno-Oncological Characteristics and Clinical Prognoses in Hepatocellular Carcinoma

SIMPLE SUMMARY: Hepatocellular carcinoma is a widespread cancer with complex molecular heterogeneity. Compared with invasive tissue sampling, the radiomics framework shows promise in non-invasively decoding tumor heterogeneity. In this study, we utilized integrative analysis of radiomics and genomic...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Yu, Huang, Hao, Tong, Qi, Cao, Meng, Ming, Wenlong, Zhang, Rongxin, Zhu, Wenyong, Wang, Yuqi, Sun, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137067/
https://www.ncbi.nlm.nih.gov/pubmed/37190266
http://dx.doi.org/10.3390/cancers15082338
_version_ 1785032369932075008
author Gu, Yu
Huang, Hao
Tong, Qi
Cao, Meng
Ming, Wenlong
Zhang, Rongxin
Zhu, Wenyong
Wang, Yuqi
Sun, Xiao
author_facet Gu, Yu
Huang, Hao
Tong, Qi
Cao, Meng
Ming, Wenlong
Zhang, Rongxin
Zhu, Wenyong
Wang, Yuqi
Sun, Xiao
author_sort Gu, Yu
collection PubMed
description SIMPLE SUMMARY: Hepatocellular carcinoma is a widespread cancer with complex molecular heterogeneity. Compared with invasive tissue sampling, the radiomics framework shows promise in non-invasively decoding tumor heterogeneity. In this study, we utilized integrative analysis of radiomics and genomics profiles to characterize hepatocellular carcinoma inter-tumor and intra-tumor heterogeneity. We extracted multi-view imaging features from contrast-enhanced CT scans, and fused features for potential radiomics subtypes identification. Differentiated immune pathway activity and inflammatory tumor microenvironment between subtypes were obtained, and the predominant radiogenomics association between texture-related and immune-related was demonstrated and validated in independent cohorts. These findings could provide clues for non-invasive inflammation-based risk stratification in hepatocellular carcinoma. ABSTRACT: Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies worldwide, and the pronounced intra- and inter-tumor heterogeneity restricts clinical benefits. Dissecting molecular heterogeneity in HCC is commonly explored by endoscopic biopsy or surgical forceps, but invasive tissue sampling and possible complications limit the broadeer adoption. The radiomics framework is a promising non-invasive strategy for tumor heterogeneity decoding, and the linkage between radiomics and immuno-oncological characteristics is worth further in-depth study. In this study, we extracted multi-view imaging features from contrast-enhanced CT (CE-CT) scans of HCC patients, followed by developing a fused imaging feature subtyping (FIFS) model to identify two distinct radiomics subtypes. We observed two subtypes of patients with distinct texture-dominated radiomics profiles and prognostic outcomes, and the radiomics subtype identified by FIFS model was an independent prognostic factor. The heterogeneity was mainly attributed to inflammatory pathway activity and the tumor immune microenvironment. The predominant radiogenomics association was identified between texture-related features and immune-related pathways by integrating network analysis, and was validated in two independent cohorts. Collectively, this work described the close connections between multi-view radiomics features and immuno-oncological characteristics in HCC, and our integrative radiogenomics analysis strategy may provide clues to non-invasive inflammation-based risk stratification.
format Online
Article
Text
id pubmed-10137067
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101370672023-04-28 Multi-View Radiomics Feature Fusion Reveals Distinct Immuno-Oncological Characteristics and Clinical Prognoses in Hepatocellular Carcinoma Gu, Yu Huang, Hao Tong, Qi Cao, Meng Ming, Wenlong Zhang, Rongxin Zhu, Wenyong Wang, Yuqi Sun, Xiao Cancers (Basel) Article SIMPLE SUMMARY: Hepatocellular carcinoma is a widespread cancer with complex molecular heterogeneity. Compared with invasive tissue sampling, the radiomics framework shows promise in non-invasively decoding tumor heterogeneity. In this study, we utilized integrative analysis of radiomics and genomics profiles to characterize hepatocellular carcinoma inter-tumor and intra-tumor heterogeneity. We extracted multi-view imaging features from contrast-enhanced CT scans, and fused features for potential radiomics subtypes identification. Differentiated immune pathway activity and inflammatory tumor microenvironment between subtypes were obtained, and the predominant radiogenomics association between texture-related and immune-related was demonstrated and validated in independent cohorts. These findings could provide clues for non-invasive inflammation-based risk stratification in hepatocellular carcinoma. ABSTRACT: Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies worldwide, and the pronounced intra- and inter-tumor heterogeneity restricts clinical benefits. Dissecting molecular heterogeneity in HCC is commonly explored by endoscopic biopsy or surgical forceps, but invasive tissue sampling and possible complications limit the broadeer adoption. The radiomics framework is a promising non-invasive strategy for tumor heterogeneity decoding, and the linkage between radiomics and immuno-oncological characteristics is worth further in-depth study. In this study, we extracted multi-view imaging features from contrast-enhanced CT (CE-CT) scans of HCC patients, followed by developing a fused imaging feature subtyping (FIFS) model to identify two distinct radiomics subtypes. We observed two subtypes of patients with distinct texture-dominated radiomics profiles and prognostic outcomes, and the radiomics subtype identified by FIFS model was an independent prognostic factor. The heterogeneity was mainly attributed to inflammatory pathway activity and the tumor immune microenvironment. The predominant radiogenomics association was identified between texture-related features and immune-related pathways by integrating network analysis, and was validated in two independent cohorts. Collectively, this work described the close connections between multi-view radiomics features and immuno-oncological characteristics in HCC, and our integrative radiogenomics analysis strategy may provide clues to non-invasive inflammation-based risk stratification. MDPI 2023-04-17 /pmc/articles/PMC10137067/ /pubmed/37190266 http://dx.doi.org/10.3390/cancers15082338 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Gu, Yu
Huang, Hao
Tong, Qi
Cao, Meng
Ming, Wenlong
Zhang, Rongxin
Zhu, Wenyong
Wang, Yuqi
Sun, Xiao
Multi-View Radiomics Feature Fusion Reveals Distinct Immuno-Oncological Characteristics and Clinical Prognoses in Hepatocellular Carcinoma
title Multi-View Radiomics Feature Fusion Reveals Distinct Immuno-Oncological Characteristics and Clinical Prognoses in Hepatocellular Carcinoma
title_full Multi-View Radiomics Feature Fusion Reveals Distinct Immuno-Oncological Characteristics and Clinical Prognoses in Hepatocellular Carcinoma
title_fullStr Multi-View Radiomics Feature Fusion Reveals Distinct Immuno-Oncological Characteristics and Clinical Prognoses in Hepatocellular Carcinoma
title_full_unstemmed Multi-View Radiomics Feature Fusion Reveals Distinct Immuno-Oncological Characteristics and Clinical Prognoses in Hepatocellular Carcinoma
title_short Multi-View Radiomics Feature Fusion Reveals Distinct Immuno-Oncological Characteristics and Clinical Prognoses in Hepatocellular Carcinoma
title_sort multi-view radiomics feature fusion reveals distinct immuno-oncological characteristics and clinical prognoses in hepatocellular carcinoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137067/
https://www.ncbi.nlm.nih.gov/pubmed/37190266
http://dx.doi.org/10.3390/cancers15082338
work_keys_str_mv AT guyu multiviewradiomicsfeaturefusionrevealsdistinctimmunooncologicalcharacteristicsandclinicalprognosesinhepatocellularcarcinoma
AT huanghao multiviewradiomicsfeaturefusionrevealsdistinctimmunooncologicalcharacteristicsandclinicalprognosesinhepatocellularcarcinoma
AT tongqi multiviewradiomicsfeaturefusionrevealsdistinctimmunooncologicalcharacteristicsandclinicalprognosesinhepatocellularcarcinoma
AT caomeng multiviewradiomicsfeaturefusionrevealsdistinctimmunooncologicalcharacteristicsandclinicalprognosesinhepatocellularcarcinoma
AT mingwenlong multiviewradiomicsfeaturefusionrevealsdistinctimmunooncologicalcharacteristicsandclinicalprognosesinhepatocellularcarcinoma
AT zhangrongxin multiviewradiomicsfeaturefusionrevealsdistinctimmunooncologicalcharacteristicsandclinicalprognosesinhepatocellularcarcinoma
AT zhuwenyong multiviewradiomicsfeaturefusionrevealsdistinctimmunooncologicalcharacteristicsandclinicalprognosesinhepatocellularcarcinoma
AT wangyuqi multiviewradiomicsfeaturefusionrevealsdistinctimmunooncologicalcharacteristicsandclinicalprognosesinhepatocellularcarcinoma
AT sunxiao multiviewradiomicsfeaturefusionrevealsdistinctimmunooncologicalcharacteristicsandclinicalprognosesinhepatocellularcarcinoma